These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Are placebo-controlled trials still important for obsessive compulsive disorder?
    Author: Fineberg NA, Hawley CJ, Gale TM.
    Journal: Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):413-22. PubMed ID: 16413647.
    Abstract:
    The use of placebos as reference agents in randomised controlled trials for psychiatric disorders has come under question for ethical reasons. Alternative methods for validating the efficacy of new treatments exist, but may not be as reliable as placebo. In this paper we examine arguments for and against the ongoing use of placebo agents in the development of new treatments for obsessive compulsive disorder in the context of evidence from randomised controlled trials.
    [Abstract] [Full Text] [Related] [New Search]